EBS:NYSE
Emergent Biosolutions Inc
US$ ६.९१
०.००%
(०.००) 1D
US$ ६.९०
arrow_downward
-०.१४% (-०.०१००)bedtimeAfter hours
Closed: अक्टोबर १४, १६:००:०३ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EBS...
Open
US$ ६.८७
High
US$ ७.०७
Low
US$ ६.८१
Mkt. cap
३५.४३ करोड
Avg. vol.
११.३६ लाख
Volume
७.६१ लाख
52-wk high
US$ १४.०६
52-wk low
US$ ४.३६
EPS
-US$ ३.५१
Beta
२.२८
Shares outstanding
५.१३ करोड
No. of employees
९००
Open
US$ ६.८७
High
US$ ७.०७
Low
US$ ६.८१
Mkt. cap
३५.४३ करोड
Avg. vol.
११.३६ लाख
Volume
७.६१ लाख
52-wk high
US$ १४.०६
52-wk low
US$ ४.३६
EPS
-US$ ३.५१
Beta
२.२८
Shares outstanding
५.१३ करोड
No. of employees
९००
News stories
From web sources and news partners
GlobeNewswire
·
१ घण्टा पहिले
Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance
·
३२ मिनेट पहिले
Update: Nasdaq, S&P 500 Fall for Third Straight Session Following Hot CPI Data
MarketBeat
·
१२ मिनेट पहिले
SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $28,720.00 in Stock
Investor's Business Daily
·
३५ मिनेट पहिले
Nasdaq, Small Caps Hit On AI Worries, Pesky Inflation: Dell, GILD, THC In Focus
Profile
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.
During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. Wikipedia
About Emergent Biosolutions Inc
CEORobert G. Kramer Sr. | Joseph C. Papa
Employees९००
Founded१९९८ सेप्टेम्बर ५
HeadquartersRockville, मेरिल्यान्ड, संयुक्त राज्य अमेरिका
Sector-
Websiteemergentbiosolutions.com